Septerna (SEPN) Assets (2023 - 2026)
Septerna (SEPN) recorded quarterly Assets of $569.7 million in Q1 2026, down 4.44% quarter-over-quarter from $596.2 million in Q4 2025, and up 31.26% on a YoY basis from $434.0 million in Q1 2025.
Septerna (SEPN) Assets (2023 - 2026) Analysis & Trends
Septerna's Assets history runs 4 years deep, the most recent figure standing at $569.7 million for Q1 2026.
- In Q1 2026, Assets rose 31.26% year-over-year to $569.7 million; the TTM figure through Mar 2026 stood at $569.7 million (up 31.26% YoY), while the FY2025 annual figure was $596.2 million, up 30.58% from the prior year.
- Assets was $569.7 million for Q1 2026 at Septerna, down from $596.2 million in the prior quarter.
- In the past five years, Assets ranged from a high of $606.7 million in Q3 2025 to a low of $130.9 million in Q4 2023.
- Historically, Assets has averaged $422.9 million across 4 years, with a median of $445.3 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Assets surged 248.87% in 2024, then surged 30.58% in 2025.
- A 4-year view of Assets shows it stood at $130.9 million in 2023, then soared by 248.87% to $456.6 million in 2024, then surged by 30.58% to $596.2 million in 2025, then retreated by 4.44% to $569.7 million in 2026.
- The last three Assets figures came in at $569.7 million (Q1 2026), $596.2 million (Q4 2025), and $606.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.37 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 811.27 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 14.93 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.73 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 23.64 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 33.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 12.81 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.48 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 640.56 Mn |
| 10 | Septerna | 1.62 Bn | 1.62 Bn | - | 569.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 569.69 Mn |
| Dec 31, 2025 | 596.19 Mn |
| Sep 30, 2025 | 606.65 Mn |
| Jun 30, 2025 | 415.23 Mn |
| Mar 31, 2025 | 434.02 Mn |
| Dec 31, 2024 | 456.55 Mn |
| Sep 30, 2024 | 174.28 Mn |
| Dec 31, 2023 | 130.87 Mn |